Stefan M. Nidorf - Concepedia

Author

Stefan M. Nidorf

Also Known As

S M Nidorf, S Mark Nidorf, S Nidorf, S. M NIDORF, S. Mark Nidorf, S. Nidorf, S.M. Nidorf, Stefan M Nidorf, Stefan M. Nidorf, Stefan Mark Nidorf

Publications

Citations

H-Index

Concepts

All Affiliations

Sir Charles Gairdner Hospital McMaster University Meander Medisch Centrum Radboud University Medical Center The University of Western Australia

About

Stefan M. Nidorf is an author at Sir Charles Gairdner Hospital specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	2K
2	Public Health	4	4	305
3	Engineering	1	1	30
4	Health Sciences	1	1	27
5	Anesthesia	1	1	19

Stefan M. Nidorf

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Colchicine in Patients with Chronic Coronary Disease Stefan M. Nidorf, Aernoud T.L. Fiolet, Arend Mosterd, New England Journal of Medicine	2020	1.9K
Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease Stefan M. Nidorf, John W. Eikelboom, Charley Budgeon, Journal of the American College of Cardiology Cardiovascular DiseasePharmacologyCardiovascular PharmacologyPharmacotherapyMedicine	2012	1K
Coronary thrombolysis and myocardial salvage by tissue plasminogen activator given up to 4 hours after onset of myocardial infarction Peter L. Thompson, Philip E. Aylward, J. Federman, The Lancet ThrombosisCardiovascular DiseaseCoronary ThrombolysisTissue Plasminogen ActivatorFibrinolysis	1988	287
New perspectives in the assessment of cardiac chamber dimensions during development and adulthood Stefan M. Nidorf, Michael H. Picard, Marco O. Triulzi, Journal of the American College of Cardiology Heart FailureCardiac Chamber DimensionsCardiovascular DiseaseCardiac AnatomyCardiac Physiology	1992	227
The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics Stefan M. Nidorf, Aernoud T.L. Fiolet, John W. Eikelboom, American Heart Journal Cardiovascular DiseaseLow-dose ColchicinePharmacologyClinical TrialsLodoco2 Trial Rationale	2019	102
Benefit of late coronary reperfusion on ventricular morphology and function after myocardial infarction Stefan M. Nidorf, Samuel C. Siu, Gabe S. Galambos, Journal of the American College of Cardiology Ventricular MorphologyCardiovascular DiseaseAcute Myocardial InfarctionMedicineCardiology	1993	80
Low-dose colchicine for atherosclerosis: long-term safety Stefan M. Nidorf, Eldad Ben‐Chetrit, Paul M. Ridker European Heart Journal	2024	58
Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome Tjerk S.J. Opstal, Aernoud T.L. Fiolet, Amber van Broekhoven, Journal of the American College of Cardiology Percutaneous Coronary InterventionCardiovascular DiseaseAtherosclerosisMedicineCardiology	2021	52
Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials Aernoud T.L. Fiolet, Michiel H.F. Poorthuis, Tjerk S.J. Opstal, EClinicalMedicine	2024	49
Optimal stage duration in dobutamine stress echocardiography Neil J. Weissman, Stefan M. Nidorf, J. Luis Guerrero, Journal of the American College of Cardiology Cardiovascular DiseaseCardiac MechanicStressOptimal Stage DurationPublic Health	1995	34

Page 1